SCPH has been granted a new patent
Jun 26, 2024, 10:38 PM
12.06%
What does SCPH do
scPharmaceuticals, Inc., based in Burlington, Massachusetts, focuses on developing subcutaneous pharmaceutical products like FUROSCIX for conditions such as congestive heart failure and infection treatments. The company, founded with 96 employees, went public in 2017 and prioritizes healthcare cost reduction and improved health outcomes.
SCPH filed a patent for "pharmaceutical formulations for subcutaneous administration of furosemide" on Fri, August 5, 2022. The patent was officially published on Thu, June 29, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.